These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8898170)
1. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer. Bolis G; van Zainten-Przybysz I; Scarfone G; Zanaboni F; Scarabelli C; Tateo S; Calabrese M; Parazzini F Gynecol Oncol; 1996 Oct; 63(1):62-5. PubMed ID: 8898170 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy. Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. Iwasaka T; Fukuda K; Hara K; Yokoyama M; Nakao Y; Uchiyama M; Sugimori H Gynecol Oncol; 1998 Aug; 70(2):236-40. PubMed ID: 9740697 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study. Chen H; Liang C; Zhang L; Huang S; Wu X Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer. Maneo A; Chiari S; Bonazzi C; Mangioni C Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350 [TBL] [Abstract][Full Text] [Related]
9. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma]. Cheng XD; Lü WG; Ye F; Chen HZ; Xie X Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer. Bae JH; Lee SJ; Lee A; Park YG; Bae SN; Park JS; Namkoong SE Gynecol Oncol; 2008 Dec; 111(3):444-8. PubMed ID: 18829085 [TBL] [Abstract][Full Text] [Related]
12. Radical surgery after neoadjuvant intra-arterial chemotherapy in stage IIIb squamous cell carcinoma of the cervix. Sugiyama T; Nishida T; Muraoka Y; Tokuda T; Kuromatsu H; Fujiyoshi K; Yakushiji M; Edamitu O; Haynbuchi N Int Surg; 1999; 84(1):67-73. PubMed ID: 10421022 [TBL] [Abstract][Full Text] [Related]
13. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb. Panetta A; Angelelli B; Martoni A Anticancer Res; 1999; 19(1B):765-8. PubMed ID: 10216490 [TBL] [Abstract][Full Text] [Related]
14. Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer? Bader AA; Winter R; Moinfar F; Petru E; Pristauz G; Scholz HS; Haas J; Tamussino KF Gynecol Oncol; 2006 Oct; 103(1):106-12. PubMed ID: 16564076 [TBL] [Abstract][Full Text] [Related]
15. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643 [TBL] [Abstract][Full Text] [Related]
16. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study. Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371 [TBL] [Abstract][Full Text] [Related]
17. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes. Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106 [TBL] [Abstract][Full Text] [Related]
18. Locally advanced cervical adenocarcinoma: is there a place for chemo-surgical treatment? Benedetti-Panici P; Greggi S; Scambia G; Salerno MG; Amoroso M; Maneschi F; Cutillo G; Caruso A; Capelli A; Mancuso S Gynecol Oncol; 1996 Apr; 61(1):44-9. PubMed ID: 8626116 [TBL] [Abstract][Full Text] [Related]